Clinical Trial

Optimal Prostate Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To compare the toxicity, rate of local control, biochemical failure rate and quality of life of three different radiotherapy techniques (moderate hypofractionation, stereotactic body radiotherapy (SBRT) and standard radiotherapy plus 2 fractions of SBRT (BOOSTER)
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2017-12-20; most recent amendment 2026-01-27.
Status change: Recruiting → Active, Not Recruiting 2026-01-27
Status change: Not Yet Recruiting → Recruiting 2018-10-23
Trial Details
NCT Number NCT03386045
Lead Sponsor Royal North Shore Hospital
Conditions Prostate Cancer
Enrollment 503 participants
Start Date 2018-10-02
Primary Completion 2028-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29